NCT07299981

Brief Summary

While the effectiveness of intravenous thrombolysis (IVT) decreases over time, patients show considerable variability in how quickly their ischemic core progresses. Quantitative net water uptake (NWU) has emerged as a biomarker indicating blood-brain barrier disruption and may better reflect the "tissue clock" than time alone. Low NWU is associated with favorable outcomes, whereas high NWU predicts poor outcomes and futile recanalization. The study aims to determine whether NWU measured on initial non-contrast CT is a treatment effect modifier for the IVT therapy.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
14mo left

Started Jan 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress23%
Jan 2026Jul 2027

First Submitted

Initial submission to the registry

December 10, 2025

Completed
13 days until next milestone

First Posted

Study publicly available on registry

December 23, 2025

Completed
9 days until next milestone

Study Start

First participant enrolled

January 1, 2026

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2027

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2027

Last Updated

January 20, 2026

Status Verified

January 1, 2026

Enrollment Period

1.2 years

First QC Date

December 10, 2025

Last Update Submit

January 15, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of participants with functional independence (modified Rankin Scale score 0-1)

    Functional independence defined as a modified Rankin Scale (mRS) score of 0-1 assessed at 90 days.

    at 90 days

Secondary Outcomes (3)

  • Number of participants with symptomatic intracerebral hemorrhage

    at 24 hours

  • Number of participants with intracerebral hemorrhage on follow-up brain imaging

    at 24 hours

  • Mortality

    at 90 days

Study Arms (1)

patients with ischemic stroke receiving IVT

Other: No Interventions

Interventions

Not applicable as this is an observational, retrospective study.

patients with ischemic stroke receiving IVT

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients aged over 18 years with acute ischemic stroke, symptom onset within 24 hours prior to admission and treatment in one of the stroke units of the participating institutions between 2018 and 2025 treated using IVT and fullfilling inclusion criteria

You may qualify if:

  • Acute ischemic stroke treated with intravenous thrombolysis
  • Imaging with non-contrast cranial CT on admission
  • Follow-up imaging with non-contrast cranial CT or MRI 12-24 hours after IVT
  • Final Infarct volume \> 5ml
  • ASPECTS available

You may not qualify if:

  • Known use of oral anticoagulation (OAC) on admission
  • Preexisting ischemic infarction on admission non-contrast cranial CT
  • Patients with large vessel occlusion AIS who underwent mechanical thrombectomy
  • Low imaging quality precluding radiological measurements
  • Severe white matter lesions precluding radiological measurements
  • No ASPECTS

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Ischemic Stroke

Condition Hierarchy (Ancestors)

StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 10, 2025

First Posted

December 23, 2025

Study Start

January 1, 2026

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

July 1, 2027

Last Updated

January 20, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will share

Individual participant data that underlie the results after deidentification

Shared Documents
STUDY PROTOCOL, SAP
Access Criteria
Data that support the findings of this study will be available from the corresponding author after academic board review and upon reasonable request